Regents of the University of California’s Jazz Pharmaceuticals JAZZ Stock Holding History

Regents of the University of California’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-14,480	Closed	-$2.13M	–	82
2014 Q2	$2.13M	Buy	+14,480	New	+$2.01M	1.15%	45

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.62B AUM 39.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Regents of the University of California's JAZZ Position: Q3 2014 in Review

Regents of the University of California sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2014, closing a stake of 14,480 shares — an estimated $2.13M sold.

Regents of the University of California first reported a position in JAZZ in Q2 2014 and held it in 1 quarter. The position peaked at $2.13M in Q2 2014. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2014.

Regents of the University of California reported no remaining Jazz Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
Regents of the University of California sold 14,480 Jazz Pharmaceuticals shares in Q3 2014, an estimated $2.13M.
Regents of the University of California first reported a position in Jazz Pharmaceuticals in Q2 2014 and held it in 1 quarter.
Regents of the University of California's Jazz Pharmaceuticals position peaked at $2.13M in Q2 2014.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2014.

Based on Regents of the University of California's 13F filing for Q3 2014, filed 28 Oct 2014.